ArticleBritish journal of pharmacology2012

Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts.

L N Axelsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.